| Literature DB >> 30637250 |
Narongsak Rungsakulkij1, Pongsatorn Tangtawee2, Wikran Suragul2, Paramin Muangkaew2, Somkit Mingphruedhi2, Suraida Aeesoa2.
Abstract
BACKGROUND: Pancreaticoduodenectomy (PD) is a complex surgical procedure with a high morbidity rate. The serious complications are major risk factors for poor long-term surgical outcome. Studies have reported an association between early postoperative prognostic nutritional index (PNI) and prediction of severe complications after abdominal surgery. However, there have been no studies on the use of early postoperative PNI for predicting serious complications following PD. AIM: To analyze the risk factors and early postoperative PNI for predicting severe complications following PD.Entities:
Keywords: Pancreatectomy; Postoperative complications; Prognostic nutritional index; Risk factors; Serum albumin
Year: 2019 PMID: 30637250 PMCID: PMC6327128 DOI: 10.12998/wjcc.v7.i1.28
Source DB: PubMed Journal: World J Clin Cases ISSN: 2307-8960 Impact factor: 1.337
Overall complications following pancreaticoduodenectomy
| No | 81 (34.03) | ||
| yes | 157 (65.97) | ||
| Postoperative pancreatic fistula | 118 (49.58) | ||
| Grade BL | 62 (26.05) | ||
| Grade B | 38 (15.97) | ||
| Grade C | 18 (7.56) | ||
| Surgical site infection | 32 (13.45) | ||
| Intra-abdominal abscess | 31 (13.02) | ||
| Delayed gastric emptying | 23 (9.66) | ||
| Bile leak | 15 (6.30) | ||
| Chyle leak | 10 (4.20) | ||
| Intraperitoneal hemorrhage | 9 (3.78) | ||
| Acute kidney injury | 8 (3.36) | ||
| Cholangitis | 7 (2.94) | ||
| Lung atelectasis | 5 (2.10) | ||
| Septicemia | 5 (2.10) | ||
| Gastrointestinal hemorrhage | 4 (1.68) | ||
| Pleural effusion | 4 (1.68) | ||
| Pneumonia | 4 (1.68) | ||
| Intestinal obstruction | 3 (1.26) | ||
| Pulmonary embolism | 3 (1.26) | ||
| Acute pancreatitis | 2 (0.84) | ||
| Delirium | 2 (0.84) | ||
| Respiratory failure | 2 (0.84) | ||
| Cerebrovascular accident | 1 (0.42) | ||
| Hepatic failure | 1 (0.42) | ||
| Urinary tract infection | 1 (0.42) | ||
| Death | 9 (3.78) | ||
BL: Biochemical leakage.
Clinicopathological characteristics in grade 0-II and III-V complication groups
| Age (yr), mean (SD) | 60.01 (11.01) | 59.89 (11.40) | 60.33 (9.91) | 0.788 | |
| Gender, | |||||
| Male | 125 (52.52) | 95 (54.29) | 30 (47.62) | 0.364 | |
| Female | 113 (47.48) | 80 (45.71) | 33 (52.38) | ||
| BMI (kg/m2), median (range) | 22.10 (15.11-38.95) | 21.85 (15.11-38.95) | 22.65 (16.22-35.34) | < 0.05 | |
| Diabetes mellitus, | |||||
| No | 173 (72.69) | 123 (70.29) | 50 (79.37) | 0.165 | |
| Yes | 65 (27.31) | 52 (29.71) | 13 (20.63) | ||
| ASA class, | |||||
| I | 6 (2.56) | 3 (1.75) | 3 (4.76) | < 0.05 | |
| II | 80 (34.19) | 64 (37.43) | 16 (25.40) | ||
| III | 135 (57.69) | 97 (56.73) | 38 (60.32) | ||
| IV | 10 (4.27) | 6 (3.51) | 4 (6.35) | ||
| V | 3 (1.28) | 1 (0.58) | 2 (3.17) | ||
| Smoking, | |||||
| No | 163 (68.49) | 115 (65.71) | 48 (76.19) | 0.125 | |
| Yes | 75 (31.51) | 60 (34.29) | 15 (23.81) | ||
| Previous biliary intervention, | |||||
| No | 84 (35.29) | 60 (34.29) | 24 (38.10) | 0.587 | |
| Yes | 154 (64.71) | 115 (65.71) | 39 (61.90) | ||
| Total bilirubin (mg/dL), median (range) | 1.20 (0.10-35.0) | 1.20 (0.10-35.0) | 1.30 (0.20-25.0) | 0.956 | |
| Albumin (g/L), median (range) | 34.9 (18.7-49.0) | 35 (18.7-49.0) | 34.1 (23.1-45.0) | < 0.05 | |
| ≥ 35 | 116 (48.47) | 91 (52.0) | 25 (39.68) | 0.093 | |
| < 35 | 122 (51.26) | 84 (48.0) | 38 (60.32) | ||
| Preoperative diagnosis, | |||||
| Benign | 55 (23.11) | 43 (24.57) | 12 (19.05) | 0.372 | |
| Malignant | 183 (76.89) | 132 (75.43) | 51 (80.95) | ||
| Pancreatic, n (%) | |||||
| Pancreatic | 131 (55.04) | 95 (54.29) | 36 (57.14) | 0.696 | |
| Nonpancreatic | 107 (44.96) | 80 (45.71) | 27 (42.86) | ||
| Operating time, median (range) | 465 (240-900) | 420 (240-900) | 480 (270-840) | 0.175 | |
| Blood loss (mL), median (range), | 800 (100-13 000) | 800 (100-8000) | 1000 (150-13 000) | 0.051 | |
| Pancreatic texture, | |||||
| Hard firm | 113 (49.78) | 88 (52.69) | 25 (41.67) | 0.143 | |
| Soft | 114 (50.22) | 79 (47.31) | 35 (58.33) | ||
| Pancreatic diameter (mm) median (range), | 3 (1-20) | 3 (1-20) | 4 (1-20) | 0.718 | |
| PNI, median (range) | |||||
| Preoperative, | 98.9 (0.4-382.2) | 98.9 (0.4-382.2) | 101.5 (39.2-204.9) | 0.456 | |
| POD 1, | 49.3 (0.2-111.6) | 56.3 (0.2-425.6) | 45.3 (0.2-111.6) | 0.060 | |
| POD 2, | 43.1 (0.2-331.1) | 45.5 (0.2-331.1) | 35.2 (0.2-78.2) | < 0.05 | |
| POD 3, | 40.5 (0.1-290.2) | 45.5 (0.2-290.2) | 30.0 (0.1-85.9) | < 0.01 | |
| POD 4, | 31.7 (0.2-205.8) | 36.8 (0.2-205.8) | 27.1 (0.2-61.4) | 0.112 | |
| POD 5, | 41.0 (0.1-147.4) | 38.7 (0.1-147.4) | 41.8 (0.2-123.2) | 0.396 | |
BMI: Body mass index; PNI: Prognostic nutritional index; POD: Postoperative day; SD: Standard deviation.
Figure 1Receiver operating characteristic curves for predicting grade III-V complications with postoperative day 3 prognostic nutritional index < 40.5. ROC: Receiver operating characteristic.
Figure 2Comparison between low (< 40.5) and high (≥ 40.5) postoperative day 3 prognostic nutritional index in grade 0-II and III-V groups. PNI: Prognostic nutritional index.
Univariate and multivariate analysis of the factors associated with grade III-V complications
| Age (yr) | 1.003 (0.97-1.03) | 0.787 | ||||
| Gender | ||||||
| Male | 1 | |||||
| Female | 1.306 (0.73-2.32) | 0.364 | ||||
| BMI (kg/m2) | 1.055 (0.98-1.13) | 0.135 | ||||
| Diabetes mellitus | ||||||
| No | 1 | |||||
| Yes | 0.615 (0.31-1.22) | 0.168 | ||||
| ASA class | ||||||
| I | 1 | |||||
| II | 0.250 (0.04-1.35) | 0.108 | ||||
| III | 0.391 (0.07-2.02) | 0.264 | ||||
| IV | 0.667 (0.08-5.12) | 0.697 | ||||
| V | 2.00 (0.11-35.80) | 0.638 | ||||
| Smoking | ||||||
| No | 1 | |||||
| Yes | 0.598 (0.31-1.15) | 0.127 | ||||
| Previous biliary intervention | ||||||
| No | 1 | |||||
| Yes | 0.847 (0.46-1.53) | 0.588 | ||||
| Total bilirubin (mg/d/L) | 0.994 (0.93-1.05) | 0.850 | ||||
| Albumin (g/L) | 0.943 (0.89-0.99) | < 0.05 | 0.883 (0.80-0.96) | < 0.01 | ||
| Preoperative diagnosis | ||||||
| Benign | 1 | |||||
| Malignant | 1.384 (0.67-2.83) | 0.374 | ||||
| Pancreatic | ||||||
| Pancreatic | 1 | |||||
| Nonpancreatic | 0.890 (0.49-1.59) | 0.696 | ||||
| Operating time | 1.002 (0.99-1.01) | 0.154 | ||||
| Blood loss (mL) | 1.254 (1.02-1.54) | 0.030 | ||||
| Pancreatic texture | ||||||
| Hard/firm | 1 | |||||
| Soft | 1.559 (0.85-2.83) | 0.144 | ||||
| Pancreatic diameter (mm) | 0.994 (0.88-1.12) | 0.921 | ||||
| PNI (POD 3) | 0.981 (0.96-0.99) | < 0.05 | ||||
| ≥ 40.5 | 1 | 1 | ||||
| < 40.5 | 2.619 (1.17-5.83) | < 0.05 | 2.776 (1.21-6.38) | < 0.05 | ||
BMI: Body mass index; CI: Confidence interval; OR: Odds ratio; PNI: Prognostic nutritional index; POD: Postoperative day.